CA
NZ
UK
AU
IND
US
Aardvark Therapeutics (NASDAQ:AARD) shares fell 43.04% to $2.25 on Friday, October 23, 2026, from a prior close of about $3.95 (calculated). The decline came on the day the company published exploratory data from its terminated Phase 3 HERO trial and the open-label extension study …
AI OKTO (NASDAQ:AIOK) shares fell 12.19% to $4.25 on Friday, October 23, 2026, in the regular session. The company has not announced a separate catalyst, and the most recent filing is a Form F-3 shelf registration dated October 20, 2026.
Seven small caps tied to artificial intelligence moved in both directions on Friday, October 23, 2026, and none of the companies has announced a catalyst. Veea (NASDAQ:VEEA) rose 23.51% to $5.18 and Xiao-I (NASDAQ:AIXI) rose 23.39% to $3.06, while Sagtec Global (NASDAQ:SAGT) added 12.93% …
Algorhythm Holdings (NASDAQ:RIME) shares fell 18.24% to $0.0995 on Friday, October 23, 2026, in the regular session. The company has not announced a catalyst for the decline, and its most recent releases concern an energy acquisition and a financing change.
Six Nasdaq small caps with operations in Japan, Southeast Asia or nearby markets moved sharply on Friday, October 23, 2026, and none has announced a catalyst. CTW (NASDAQ:CTW), a Tokyo game platform, fell 11.62% to $1.75 a week after a fiscal 2026 net loss …
AsiaStrategy (NASDAQ:SORA) shares rose 10.86% to $2.45 on Friday, October 23, 2026, in regular trading. That implies a prior close of about $2.21 (calculated). The company has not announced a catalyst, and its most recent releases date from earlier in the month.
Atlantic American (NASDAQ:AAME) shares fell 15.79% to $1.33 on Friday, October 23, 2026. The decline followed a company announcement dated October 22, 2026, that Nasdaq had issued a Staff Delisting Determination.
authID (NASDAQ:AUID) shares fell 14.02% to $0.3018 on Friday, October 23, 2026, during the regular session. The company has not announced a catalyst for the decline, and its latest release is a financing announced on October 5, 2026.
BIO-key (NASDAQ:BKYI) shares rose 29.19% to $3.54 on Friday, October 23, 2026. The company has not announced a catalyst for the session, and its latest dated disclosure is its second-quarter report from August 13.
Aardvark Therapeutics (NASDAQ:AARD) fell 43.04% to $2.25 after exploratory data from its terminated Phase 3 HERO trial, and Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) dropped 28.60% to $0.3495 with no announced catalyst. MacroGenics (NASDAQ:MGNX) lost 20.11% to $2.90 on the day of a scheduled poster, Phathom Pharmaceuticals …
Please wait processing your request...